PharmiWeb.com - Global Pharma News & Resources
28-Jun-2019

Autoimmune Disease Diagnostics Market Size Poised to Touch USD 16 Billion by 2026

The Global Autoimmune Disease Diagnostics Market Size is expected to reach USD 16 Billion by 2026 and growing CAGR around 2.8% during the forecast period.

According to the report named ldquo;Autoimmune disease diagnostics Marketrdquo; - Global Industry Analysis, Growth, Share, Size, Trends and Forecast, 2018-2026rdquo;, increasing occurrences of diseases, growing demand for better and accurate diagnostic procedures,rising awareness towards the benefits of early diagnosis, various research and development activities, and initiatives taken by favourable governments regulations are some of the key factors that are fueling the autoimmune disease diagnostics market growth across the globe. Autoimmune diseases are bodyrsquo;s unusual immune reaction that produce antibodies which attack own tissues and cells. This usually causes destruction and weakening of healthy tissues. Auto antibody test, complete blood count, antinuclear antibody test, erythrocyte sedimentation rate and C-reactive protein are some of the tests used for diagnosis of the autoimmune disease. North America is anticipated to witness the highest growth rate over the forecast period owing to the availability of wide range of various better and accurate disease diagnostic methods, early adoption of various advanced diagnostic methods and ongoing technological advancements in the healthcare industry. Awareness programs conducted by various organizations are also playing the major role in the growth of regional autoimmune disease diagnostics market.

Free Download Sample Report Pages For Better Understanding at https://www.acumenresearchandconsulting.com/request-sample/1177

Rising Occurrences of Diseases and Growing Demand for Better and Accurate Diagnostic Procedures to Drive the Global Autoimmune Disease Diagnostics Market Growth

Rising occurrences of various diseases such as Hashimotorsquo;s thyroiditis, rheumatoid arthritis and various initiatives taken by favourable governments are some of the fundamental factors driving the global autoimmune disease diagnostics market growth. According to the American Autoimmune Related Diseases Association, around 50 million people from the region are presently suffering from autoimmune related disorders. This factor is anticipated to create immense opportunities for the global autoimmune disease diagnostics market over the forecast period. The growing demand for improved and accurate diagnostic procedures due to the growth in prevalence of the various diseases is projected to boost the adoption of autoimmune disease diagnostics methods throughout the forecast period. Autoimmune diseases are weakly understood in recent times. In order to develop superior diagnosis and treatment methods the wide-ranging research and development activities are supported by government. Such research activities are expected to further spur the overall market growth. Several initiatives in order to decrease the cost required to cure these diseases is also anticipated to supplement the overalls market growth during the forecast period. Organizations such as Johns Hopkins and Autoimmune Research Network (ARNet) Autoimmune Disease Research Centre are currently carrying research activities in this sector. These organizations are primarily focusing on the development of the different strategies in order to cater the rising economic load. American Autoimmune Related Diseases Association has also taken a large number of initiatives in order to increase the awareness towards the advantages of early diagnosis.

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1177

Asia Pacific to Grow at Highest Rate inAutoimmune Disease Diagnostics Market

Geographically, the global autoimmune disease diagnostics market has been divided into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America is anticipated to contribute the highest revenue share and grow at highest CAGR during the forecast period owing to the availability of wide range of various better and accurate disease diagnostic methods, early adoption of various advanced diagnostic methods and ongoing technological advancements in the healthcare industry. Awareness programs conducted by various organizations are also playing the major role in the growth of regional autoimmune disease diagnostics market. Growing inclination towards more advanced disease diagnostics methods and rapid growth in the healthcare industry are supplementing the regional market growth. Asia Pacific is also expected to show substantial growth over the forecast period due to presence of large number of patient base and growing disposable income in the emerging countries. Infrastructural development and early and growing need for accurate diagnosis are some of the key factors fueling the regional market growth.

Market Players

The autoimmune disease diagnostics market is consolidated with a large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players of the market are straZeneca, Inova Diagnostics Inc., Novartis AG, Abbott Laboratories, Pfizer Inc., F. Hoffmann-La Roche, Bio-Rad Laboratories Inc., Hemagen Diagnostics Inc., Beckman Coulter Inc. and Sanofi-aventis.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Autoimmune Disease Diagnostics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Autoimmune Disease Diagnostics Market By Product
1.2.2.1. Global Autoimmune Disease Diagnostics Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Autoimmune Disease Diagnostics Market Revenue Share By Product in 2017
1.2.2.3. Systemic
1.2.2.4. Localized
1.2.2.5. Others
1.2.3. Autoimmune Disease Diagnostics Market by Geography
1.2.3.1. Global Autoimmune Disease Diagnostics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.2. North America Autoimmune Disease Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.3.3. Europe Autoimmune Disease Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.3.4. Asia-Pacific Autoimmune Disease Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.3.5. Latin America Autoimmune Disease Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.3.6. Middle East and Africa (MEA) Autoimmune Disease Diagnostics Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Autoimmune Disease Diagnostics Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Autoimmune Disease Diagnostics Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Autoimmune Disease Diagnostics Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Autoimmune Disease Diagnostics Major Manufacturers in 2017

CHAPTER 4. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY PRODUCT

4.1. Global Autoimmune Disease Diagnostics Revenue By Product
4.2. Systemic
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Localized
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Others
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY COUNTRY

5.1. North America Autoimmune Disease Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2. North America Autoimmune Disease Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
5.3. U.S.
5.3.1. U.S. Autoimmune Disease Diagnostics Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.5. Mexico
5.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 6. EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY COUNTRY

6.1. Europe Autoimmune Disease Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. Europe Autoimmune Disease Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 7. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY COUNTRY

7.1. Asia-Pacific Autoimmune Disease Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Asia-Pacific Autoimmune Disease Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. LATIN AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY COUNTRY

8.1. Latin America Autoimmune Disease Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Latin America Autoimmune Disease Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Argentina
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. MIDDLE EAST AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY COUNTRY

9.1. Middle East Autoimmune Disease Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Middle East Autoimmune Disease Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. Saudi Arabia
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. UAE
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. Rest of Middle East
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET BY COUNTRY

10.1. Africa Autoimmune Disease Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Africa Autoimmune Disease Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. South Africa
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Egypt
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Africa
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE

11.1. StraZeneca
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Inova Diagnostics Inc.
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Novartis AG
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Abbott Laboratories
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. Pfizer Inc.
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. F. Hoffmann-La Roche
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Bio-Rad Laboratories Inc.
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Hemagen Diagnostics Inc.
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. Beckman Coulter Inc.
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. Sanofi-aventis
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Others
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies

CHAPTER 12. RESEARCH APPROACH

12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/1177

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 28-Jun-2019